Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.
2.

Nephrocalcinosis and its relationship to treatment of hereditary rickets.

Goodyer PR, Kronick JB, Jequier S, Reade TM, Scriver CR.

J Pediatr. 1987 Nov;111(5):700-4.

PMID:
2822887
3.

Renal hypophosphataemia has several mendelian forms.

Scriver CR, Reade TM.

Lancet. 1987 Oct 17;2(8564):918. No abstract available.

PMID:
2889114
4.
5.

The Hartnup phenotype: Mendelian transport disorder, multifactorial disease.

Scriver CR, Mahon B, Levy HL, Clow CL, Reade TM, Kronick J, Lemieux B, Laberge C.

Am J Hum Genet. 1987 May;40(5):401-12.

6.

Ontogeny modifies manifestations of cystinuria genes: implications for counseling.

Scriver CR, Clow CL, Reade TM, Goodyer P, Auray-Blais C, Giguère R, Lemieux B.

J Pediatr. 1985 Mar;106(3):411-6.

PMID:
3919167
7.

Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.

Gundberg CM, Cole DE, Lian JB, Reade TM, Gallop PM.

J Clin Endocrinol Metab. 1983 May;56(5):1063-7.

PMID:
6601111
8.

Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia.

Cole DE, Fraser FC, Glorieux FH, Jequier S, Marie PJ, Reade TM, Scriver CR.

Am J Med Genet. 1983 Apr;14(4):725-35.

PMID:
6846403
9.

Outcome of early and long-term management of classical maple syrup urine disease.

Clow CL, Reade TM, Scriver CR.

Pediatrics. 1981 Dec;68(6):856-62.

PMID:
6798541
10.

X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization.

Costa T, Marie PJ, Scriver CR, Cole DE, Reade TM, Nogrady B, Glorieux FH, Delvin EE.

J Clin Endocrinol Metab. 1981 Mar;52(3):463-72.

PMID:
6893992
11.

Hypophosphatemic rickets and breast milk.

Reade TM, Scriver CR.

N Engl J Med. 1979 Jun 14;300(24):1397. No abstract available.

PMID:
440383
12.

Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.

Scriver CR, Reade TM, DeLuca HF, Hamstra AJ.

N Engl J Med. 1978 Nov 2;299(18):976-9.

PMID:
308618
13.

Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency.

Reade TM, Scriver CR, Glorieux FH, Nogrady B, Delvin E, Poirier R, Holick F, DeLuca HF.

Pediatr Res. 1975 Jul;9(7):593-9.

PMID:
1161348
14.

Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.

Glorieux FH, Scriver CR, Reade TM, Goldman H, Roseborough A.

N Engl J Med. 1972 Sep 7;287(10):481-7. No abstract available.

PMID:
4340235
15.

Management of hereditary metabolic disease. The role of allied health personnel.

Clow CL, Reade TM, Scriver CR.

N Engl J Med. 1971 Jun 10;284(23):1292-8. No abstract available.

PMID:
5576439

Supplemental Content

Loading ...
Support Center